{"id":"amg-386-paclitaxel-and-carboplatin","safety":{"commonSideEffects":[{"rate":"30%","effect":"Fatigue"},{"rate":"20%","effect":"Nausea"},{"rate":"15%","effect":"Vomiting"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"AMG 386 is a recombinant human angiopoietin-2 (Ang-2) decoy receptor that inhibits angiopoietin-2 activity, thereby inhibiting angiogenesis. This mechanism is thought to be beneficial in treating various cancers.","oneSentence":"Angiopoietin-2 inhibitor","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T05:54:00.033Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Ovarian cancer"},{"name":"Breast cancer"}]},"trialDetails":[{"nctId":"NCT01042379","phase":"PHASE2","title":"I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer","status":"RECRUITING","sponsor":"QuantumLeap Healthcare Collaborative","startDate":"2010-03-01","conditions":"Breast Neoplasms, Breast Cancer, Breast Tumors","enrollment":5000},{"nctId":"NCT01493505","phase":"PHASE3","title":"TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer","status":"TERMINATED","sponsor":"Amgen","startDate":"2012-01","conditions":"Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cancer","enrollment":1015},{"nctId":"NCT01253681","phase":"PHASE1","title":"Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer","status":"COMPLETED","sponsor":"Amgen","startDate":"2010-11","conditions":"Carcinoma, Fallopian Tube Cancer, Ovarian Cancer","enrollment":27}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_1","status":"active","brandName":"AMG 386, paclitaxel and carboplatin","genericName":"AMG 386, paclitaxel and carboplatin","companyName":"Amgen","companyId":"amgen","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Angiopoietin-2 inhibitor Used for Ovarian cancer, Breast cancer.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}